Oral immunotherapy with type V collagen in idiopathic pulmonary fibrosis

摘要

Idiopathic pulmonary fibrosis (IPF) is a progressive lung disease with poor prognosis. IPF appears to be heterogeneous in pathobiology with similar to 40% of IPF patients found to have elevated levels of circulating antibodies to the autoantigen type V collagen (col(V)).